Lindborg Stacy - Insider Non-Derivative Transactions at BRAINSTORM CELL THERAPEUTICS INC. (BCLI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 11, 2024, Lindborg Stacy's relationship to BRAINSTORM CELL THERAPEUTICS INC. (BCLI) is Officer (Co-Chief Executive Officer), and currently has 423,435 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BCLI insiders.
Data Source: SEC.
Lindborg Stacy - Insider Non-Derivative Transactions of BCLI Common Stock
Lindborg Stacy - Insider Non-Derivative Transactions at BCLI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 12, 2024 | Acquisition -- (Common Stock) | 241935 | 0 | 423435 |
| Sep 2, 2023 | P -- (Common Stock) | 11500 | 1.77 | 181500 |
| Aug 3, 2023 | Acquisition -- (Common Stock) | 35000 | 0 | 170000 |
| Apr 21, 2023 | Acquisition -- (Common Stock) | 75000 | 0 | 135000 |
| Dec 8, 2022 | Acquisition -- (Common Stock) | 35000 | 0 | 60000 |